Diamond Biofund
Diamond Biofund is a Taipei-based evergreen venture capital firm, founded in 2013 and listed in Taiwan, investing in biotechnology, innovative drugs and high-end medical equipment.
Diamond Biofund is a Taipei-based venture capital firm that invests in biotechnology and medical businesses. Founded in 2013, it operates an evergreen structure - a fund model without a fixed liquidation date, allowing investments to be held over longer periods - and is publicly listed in Taiwan. The firm describes its mandate as backing scientists and companies with the potential to build lasting businesses, moving laboratory discoveries through to products and commercialisation.
Sector focus covers innovative new drugs, high-end medical equipment, biotechnology and life sciences more broadly. Alongside direct venture investment, Diamond Biofund develops sustainable biotech funds in partnership with financial institutions, with the stated objective of developing flagship biotech companies. Its approach combines investment selection with hands-on support for portfolio companies.
Geographic presence centres on Taiwan, with activity extending to other international markets. The firm states an aim of becoming a first-tier international biofund and of creating value for shareholders while contributing to the development of the biotechnology sector. Team size and fund economics are not disclosed.